Balyasny Asset Management
PFE icon

Balyasny Asset Management’s Pfizer PFE Stock Holding History

Balyasny Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.3M Sell
723,700
-146,700
-17% -$3.91M 0.03% 685
2025
Q4 		$21.7M Buy
870,400
+298,700
+52% +$7.53M 0.03% 668
2025
Q3 		$14.6M Sell
571,700
-1,350,200
-70% -$33.3M 0.02% 867
2025
Q2 		$46.6M Buy
1,921,900
+1,455,300
+312% +$33.9M 0.07% 358
2025
Q1 		$11.8M Buy
466,600
+270,500
+138% +$7.08M 0.02% 822
2024
Q4 		$5.2M Sell
196,100
-52,200
-21% -$1.42M 0.01% 1262
2024
Q3 		$7.19M Sell
248,300
-67,000
-21% -$1.95M 0.01% 1104
2024
Q2 		$8.82M Sell
315,300
-539,400
-63% -$14.9M 0.02% 935
2024
Q1 		$23.7M Sell
854,700
-109,200
-11% -$3.03M 0.04% 550
2023
Q4 		$27.8M Sell
963,900
-180,400
-16% -$5.45M 0.05% 482
2023
Q3 		$38M Buy
1,144,300
+29,300
+3% +$1.04M 0.08% 350
2023
Q2 		$40.9M Buy
1,115,000
+795,900
+249% +$31M 0.09% 301
2023
Q1 		$13M Sell
319,100
-125,000
-28% -$5.4M 0.03% 675
2022
Q4 		$22.8M Buy
444,100
+19,100
+4% +$916K 0.06% 436
2022
Q3 		$18.6M Sell
425,000
-2,501,000
-85% -$122M 0.06% 450
2022
Q2 		$153M Buy
2,926,000
+2,400,000
+456% +$122M 0.5% 19
2022
Q1 		$27.2M Buy
526,000
+476,000
+952% +$24.7M 0.09% 324
2021
Q4 		$2.95M Buy
+50,000
New +$2.48M 0.01% 1049
2021
Q3 		– Sell
-931,600
Closed -$36.5M – 2314
2021
Q2 		$36.5M Buy
931,600
+541,600
+139% +$21.1M 0.17% 139
2021
Q1 		$14.1M Buy
390,000
+280,000
+255% +$9.94M 0.07% 380
2020
Q4 		$4.05M Buy
+110,000
New +$4.03M 0.02% 710
2015
Q2 		– Sell
-26,350
Closed -$870K – 1278
2015
Q1 		$870K Buy
+26,350
New +$838K 0.01% 692

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Balyasny Asset Management's PFE Position: Q1 2026 in Review

Balyasny Asset Management increased its Pfizer (PFE) stake by 23% in Q1 2026, buying an estimated $51.3M and bringing the position to 10,471,388 shares worth $294M. The position accounts for 0.38% of the portfolio, ranked #34.

Balyasny Asset Management first reported a position in PFE in Q4 2014 and has held it in 41 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Balyasny Asset Management held 10,471,388 shares of Pfizer worth $294M as of Q1 2026.
  • Balyasny Asset Management bought 1,926,496 Pfizer shares in Q1 2026, an estimated $51.3M.
  • Pfizer made up 0.38% of Balyasny Asset Management's portfolio in Q1 2026, its #34 holding.
  • Balyasny Asset Management first reported a position in Pfizer in Q4 2014 and has held it in 41 quarters since.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.